| |
| |
|
| Insider
Information: |
Megna Michael R |
| Relationship: |
|
| City: |
Rockland |
| State: |
MA |
| |
|
| Insider
Summary: |
|
|
|
|
Companies Owned : |
1 |
|
| Direct
Shares |
21,328 |
|
|
Indirect Shares
|
0 |
|
|
| Direct
Value |
$417,602 |
|
|
|
Indirect Value
|
$0 |
|
|
| Total
Shares |
21,328 |
|
|
| Total
Value |
$417,602 |
|
|
|
|
|
|
|
|
Historical
Performance :
Based on 6 Month Return Percentages |
Buys
|
Sells
|
|
Total
Filings :
|
0
|
0
|
|
Stock
price went up :
|
0
|
0
|
| Stock
price went down : |
0
|
0
|
| |
|
|
|
Gain/Loss Ratio : |
0.0
|
0.0
|
| Percentage
Gain/Loss : |
0.0%
|
0.0%
|
| |
|
|
|
|
|
Holdings
:
| Menu |
Company Name |
Ticker |
Relation |
Direct Date |
Direct Shares |
Indirect Date |
Indirect Shares |
Total Value Sold  |
 |
Kiniksa Pharmaceuticals, Ltd. |
KNSA |
|
2024-04-08 |
21,328 |
|
0 |
Premium* |
|
|
|
|
|
|
|
|
|
|
|
Records found :
25 |
Free Registration Required For Full Results. Limit: 25
|
 |
Download |
Page 1 of 1
|
| Ticker |
Company Name |
Relation |
Off-Dir-10% |
Trans. Date |
Form |
Action |
Price |
Mkt Value |
D/I |
Shares |
Holdings |
Rank
|
|
|
| 3m +/- |
|
|
Form |
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-04-08 |
4 |
D |
$17.90 |
$29,821 |
D/D |
(1,666) |
21,328 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-04-08 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,932 |
22,994 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-04-01 |
4 |
D |
$19.70 |
$21,355 |
D/D |
(1,084) |
19,062 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-04-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,558 |
20,146 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-03-01 |
4 |
OE |
$8.83 |
$105,560 |
D/D |
9,659 |
27,247 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-03-01 |
4 |
AS |
$21.45 |
$207,186 |
D/D |
(9,659) |
17,588 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-02-28 |
4 |
AS |
$21.79 |
$111,696 |
D/D |
(5,126) |
17,588 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-02-28 |
4 |
OE |
$8.83 |
$45,263 |
D/D |
5,126 |
22,714 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-01-15 |
4 |
A |
$12.35 |
$7,200 |
D/D |
583 |
17,588 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-01-02 |
4 |
OE |
$13.88 |
$231,380 |
D/D |
16,670 |
33,675 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2024-01-02 |
4 |
AS |
$19.17 |
$319,564 |
D/D |
(16,670) |
17,005 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-12-19 |
4 |
AS |
$19.13 |
$178,215 |
D/D |
(9,316) |
17,005 |
0 |
% |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-12-19 |
4 |
OE |
$13.88 |
$129,306 |
D/D |
9,316 |
26,321 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-10-04 |
4 |
D |
$16.01 |
$833 |
D/D |
(52) |
17,005 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-10-04 |
4 |
OE |
$0.00 |
$0 |
D/D |
175 |
17,057 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-09-02 |
4 |
OE |
$0.00 |
$0 |
D/D |
774 |
17,110 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-09-02 |
4 |
D |
$17.76 |
$4,049 |
D/D |
(228) |
16,882 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-09-01 |
4 |
D |
$17.76 |
$20,513 |
D/D |
(1,155) |
16,336 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-09-01 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,933 |
17,491 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-07-15 |
4 |
A |
$12.35 |
$7,175 |
D/D |
581 |
13,558 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-04-10 |
4 |
D |
$10.71 |
$12,370 |
D/D |
(1,155) |
12,977 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-04-10 |
4 |
OE |
$0.00 |
$0 |
D/D |
3,933 |
14,132 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-20 |
4 |
D |
$11.12 |
$7,061 |
D/D |
(635) |
10,199 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-20 |
4 |
OE |
$0.00 |
$0 |
D/D |
2,163 |
10,834 |
0 |
- |
|
| KNSA |
Kiniksa Pharmaceuticals, ... |
CHIEF ACCOUNTING OFFICER |
• – – |
2023-03-16 |
4 |
D |
$11.46 |
$2,533 |
D/D |
(221) |
8,671 |
0 |
- |
|
25 Records found
|
1
|
Page 1 of 1 |
| |
Free Registration Required For Full Results. Limit: 25
|
|
| |
Transaction Code Key: |
Ownership Code Key |
| |
B |
- Buy |
AB |
- Automatic Buy |
D |
- Direct Ownership |
| |
S |
- Sell |
AS |
- Automatic Sell |
I |
- Indirect Ownership |
|
OE |
- Options Exercised |
A |
- Aquired |
| |
IO |
- Initital Ownership |
D |
- Disposed |
| |
|
|
|
|
|
